France· FR:66879143
RILUZOLE TEVA 50 mg, comprimé pelliculé
A riluzole product containing riluzole, registered in France by TEVA SANTE, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Riluzole is registered in 17 of 19 countries.
Countries holding a registration under ATC N07XX02 (riluzole), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 10 of them publish a price we can compare per daily dose
Riluzole · ATC N07XX02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of riluzole costs, country by country.
Normalised to the WHO defined daily dose (0.1 g), the median price runs from $5.62 in France to $9.14 in Italy — a ×1.6 gap.
- France: $5.62 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Riluzole · price per daily dose (0.1 g)
USD · FX 28 Sept 2026
- IT Italy$9.14
- CH Switzerland$8.63
- FR France$5.62
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- RILUZOLE
- Manufacturer
- TEVA SANTE
- Country
- France (FR)
- ATC code
- N07XX02
- ATC class
- Riluzole
- Defined daily dose
- 0.1 g, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400949912469plaquette(s) aluminium PVC de 56 comprimé(s)EUR 138.33
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
46 interactions on record for riluzole.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Riluzole · interactions on record
46 records
- 4 severe
- 28 moderate
- 5 minor
- 9 info
Most severe, free to view
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- LeflunomideL04AK01severe
- TeriflunomideL04AK02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Riluzole in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaRILUTEKSanofi Winthrop Industrie, Gentilly
- SwedenGlentek 50 mg Filmdragerad tablettGlenmark Arzneimittel GmbH
- NetherlandsGlentek 50 mg filmomhulde tablettenGlenmark Arzneimittel GmbH
- FinlandRilutekParanova Oy
- BelgiumRiluzol AB 50 mgAurobindo
- SpainRILUTEK 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULASanofi Winthrop Industrie
- ItalyRILUTEKSANOFI WINTHROP INDUSTRIE
- PolandRilutekSanofi Winthrop Industrie
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Emylif, Riluzol Aristo
- Belgium · Emylif, Riluzol Ab
- Cyprus · Teglutik
- Czechia · Riluzol Pmcs
- Germany · Emylif, Glentek
- Denmark · Emylif, Glentek
- Estonia · Lizolorol, Rilustad
- Spain · Emylif, Riluzol Aurovitas
- Finland · Teglutik
- United Kingdom (Northern Ireland) · Emylif, Riluzole Accord Healthcare
- Greece · Teglutik
- Croatia · Alsemol
- Hungary · Sclefic
- Iceland · Emylif, Rilutek
- Italy · Emylif, Riluzolo Aurobindo
- Liechtenstein · Rilutek, Riluzole Zentiva
- Luxembourg · Emylif, Teglutik
- Netherlands · Emylif, Glentek
- Norway · Emylif, Rilutek
- Poland · Riluzol Pmcs, Riluzole Sun
- Portugal · Emylif, Riluzol Aurovitas
- Romania · Riluzol Pmcs
- Sweden · Emylif, Glentek
- Slovenia · Sclefic
- Slovakia · Riluzol Pmcs
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c4f19b30-1f83-4cdc-bf62-ee0a227c3b90 GET /v1/drugs/c4f19b30-1f83-4cdc-bf62-ee0a227c3b90?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66879143",
"date_amm": "2011-10-13",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "RILUZOLE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about riluzole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.